Early research (Phase 1)UnknownNCT04107142
What this trial is testing
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
Who this might be right for
Colorectal CancerTriple Negative Breast CancerSarcoma+3 more
CytoMed Therapeutics Pte Ltd 10